Hester Biosciences submits transcript of earnings conference call

19 Nov 2019 Evaluate

Hester Biosciences has informed about submission of a transcript of Earnings Conference Call held by the Management of the Company with investors on 6th November 2019 at 2.00 pm, to discuss the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended on 30 September 2019. 

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1589.00 12.35 (0.78%)
31-Dec-2025 11:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.45
Dr. Reddys Lab 1266.30
Cipla 1499.20
Zydus Lifesciences 911.05
Lupin 2093.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×